News for Professionals

News overview

Displaying results ###SPAN_BEGIN###%s to %s out of ###SPAN_BEGIN###%s

Biofrontera and Desitin sign marketing and distribution agreement for Ameluz^® in Scandinavia

07.05.2012

Biofrontera Pharma GmbH and Desitin Arzneimittel GmbH have closed an agreement in February according to which Desitin has obtained exclusive rights to market Biofrontera’s new prescription drug Ameluz^® in Denmark, Sweden and...more

New: Levetiracetam DESITIN^® minitablets* - Desitin expands its portfolio.

02.11.2011

The antiepileptic agent levetiracetam has been launched worldwide about a decade ago and has most decisively enriched the treatment of epilepsy. From May 2011 onward, Desitin introduced a Levetiracetam...more

Two new products joined Desitin's addiction portfolio in September 2010.

27.09.2010

Foundation of Desitin Pharma S.R.L. in Romania

03.09.2010

Desitin´s representative office in Bucharest (Romania) has been changed to Desitin Pharma S.R.L. and moved to new office premises. New address, contact information and more details you will find here: ->...more